Farmexim Head of Legal and Compliance Director Mihaela Scarlatescu discusses her 25-year legal journey, leading in-house strategy across pharma and retail, and balancing legal precision with business impact.
Schoenherr and Savoric & Partners Advise on Accession Capital Partners' EUR 30 Million Growth Investment into Vetti Group
Schoenherr has advised Accession Capital Partners on its EUR 30 million growth capital investment into Vetti Group. Savoric & Partners advised Vetti Group.
KSB Advises on mcePharma Sale to Brenntag Group
Kocian Solc Balastik has advised Ivan Mikes on the sale of mcePharma to the Brenntag Group. Pierstone reportedly advised Brenntag.
Gessel Advises ArKa Foundation on Sale of Med-Gastr to Tar Heel Capital
Gessel has advised the ArKa family foundation on the sale of a 75% stake in Centrum Medyczne Med-Gastr to Tar Heel Capital. Sobczynscy i Partnerzy reportedly advised Tar Heel Capital.
Sorainen Successfully Defends Gintarine Vaistine and Limedika in Antitrust Case
Sorainen has successfully represented Gintarine Vaistine and Limedika in an antitrust case before Lithuanian courts, resulting in the annulment of over EUR 25 million in cartel fines imposed by the Lithuanian Competition Council.
Greenberg Traurig and Rymarz Zdort Maruta Advise on Cheyne SVC's Private Credit Investment in LuxVet Group
Greenberg Traurig has advised Cheyne Strategic Value Credit on its private credit investment in LuxVet Group. Rymarz Zdort Maruta advised LuxVet Group.
Albania Adopts New Instruction on the Processing of Health and Genetic Data
As part of the broader effort to harmonise national legislation with the EU General Data Protection Regulation, the Albanian Data Protection Commissioner issued Instruction No. 2, dated 30 April 2025 (Instruction No. 2), on the protection of personal data in the health sector. This Instruction repeals the previous 2020 framework and establishes a comprehensive set of rules governing the collection, use, and disclosure of health and genetic data.